[Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney]

Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Apr 18;38(2):170-5.
[Article in Chinese]

Abstract

Objective: To explore the possible molecular mechanism of abnormal renal lipid metabolism in OLETF rats, and the effects of fenofibrate or metformin on renal local lipid metabolism.

Methods: OLETF rats were randomly divided into three groups: one treated with fenofibrate, one with metformin and one without treatment. LETO rats were used as age-matched normal controls. The animals were sacrificed and the kidneys were obtained respectively at the age of 17 and 30 weeks. 24-hour urine albumin contents and TG contents in renal cortex were measured.The levels of SREBP-1 protein and mRNA in kidney were measured. FAS mRNA and ACC mRNA expressions were measured with RT-PCR.

Results: OLETF rats showed characters of obesity, hyperglycemia, hyperlipidemia. At the end of thirty weeks clinical characters of renal damage appeared in OLETF rats, OLETF rats showed higher levels of 24-hour urine albumin contents than those of LETO rats. 24-hour urine albumin contents were correlated positively with TG contents in kidney. The partial correlation coefficient was 0.870 (P = 0.011) by controlling for body weight, serum lipid, blood glucose and fasting insulin concentration. OLETF rats showed higher levels of SREBP-1 protein (43.2%, P<0.01), FAS mRNA (126.0%, P<0.01), ACC mRNA (72.3%, P<0.01) than those of group LETO. OLETF/F rats showed lower levels of SREBP-1 (15.7%, P = 0.061), FAS mRNA (36.8%, P<0.05), ACC mRNA (40.3%, P<0.05) than those of group OLETF. OLETF/M rats showed lower levels of SREBP-1 (19.3%, P<0.01), FAS mRNA (57.3%, P<0.01), ACC mRNA (22.5%, P<0.05) than those of group OLETF. There was no difference in SREBP-1 mRNA levels for each group.

Conclusion: Renal damage occurred in OLETF rats at the prediabetes stage. 24-hour urine albumin contents were correlated positively with TG contents in kidney. SREBP-1 might aggravate fat deposition in kidney through some enzyme associated with fat synthesis, which was a possible pathogenesis of diabetic nephropathy. Treatment with fenofibrate or metformin ameliorated renal damage in OLETF rats through SREBP-1 and some enzyme regulated by it reduced fat deposit in kidney directly.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetic Nephropathies / pathology
  • Fenofibrate / therapeutic use*
  • Kidney / metabolism*
  • Kidney / pathology
  • Lipid Metabolism
  • Metformin / therapeutic use*
  • Rats
  • Rats, Inbred OLETF
  • Sterol Regulatory Element Binding Protein 1 / metabolism

Substances

  • Sterol Regulatory Element Binding Protein 1
  • Metformin
  • Fenofibrate